Goodrx - Company Profile

Save hours of research with our analyst-prepared profile on Goodrx. Get financials, SWOT, and competitor insights in one place—your competitors might already have it.

Goodrx Competitors

Competitor	Headquarters	No. of Employees	Revenue	Entity Type
Rite Aid	United States of America	50,000+	$23.8B	Public
Walgreens Boots Alliance	United States of America	450,000+	$139.5B	Public
CVS Health	United States of America	300,000+	$257.0B	Public
Amazon Pharmacy	United States of America	1,000,000+ (including Whole Foods)	$514.0B	Public
Express Scripts	United States of America	30,000+	$129.0B	Public
Humana	United States of America	41,600	$77.1B	Public
UnitedHealth Group	United States of America	400,000+	$324.2B	Public
Anthem	United States of America	74,500	$121.5B	Public
Cigna	United States of America	73,000+	$166.3B	Public
MedImpact Healthcare Systems	United States of America	1,500+	$1.3B	Private
OptumRx	United States of America	40,000+	$49.0B	Public
GoodNeighbor Pharmacy	United States of America	1,000+	N/A	Private
PillPack	United States of America	500+	$50M	Private
Walgreens Health	United States of America	30,000+	$16.0B	Public
SnapRX	United States of America	50+	$1.0M	Private

Overview of Goodrx's competitor analysis

GoodRx operates in a highly competitive market with several key players in the pharmacy and healthcare sectors. Major competitors include CVS Health and Walgreens Boots Alliance, both of which offer extensive pharmacy services and have large networks. Additionally, Amazon Pharmacy is rapidly emerging as a formidable competitor, leveraging its vast logistics capabilities to enhance customer access to medications. Other notable competitors like Cigna and Anthem provide robust health insurance plans that often include prescriptions. In this landscape, companies aim to differentiate themselves through cost savings, patient support programs, and digital health innovations.

What are Goodrx's key strengths compared to competitors?

GoodRx has several key strengths that set it apart from its competitors. Firstly, it offers a wide range of discounts on prescription medications, helping consumers save a significant amount of money. Secondly, its user-friendly website and mobile app simplify the process of comparing prices across pharmacies, making it easier for users to find the best deals. Additionally, GoodRx provides valuable information on drug side effects and usage, enhancing user awareness and safety. Overall, these aspects contribute to GoodRx's strong reputation in the pharmaceutical discount space.

FAQs

Who are the main competitors of goodrx?

The main competitors of GoodRx include companies like Blink Health, RxSaver, and WellRx. These competitors also provide price comparison tools for prescription drugs and similar discount services. Each of these companies aims to support consumers in lowering their medication costs, creating a competitive landscape in the pharmaceutical price comparison market.

Which company is the largest competitor of goodrx in terms of revenue?

As of recent data, Blink Health is recognized as the largest competitor of GoodRx in terms of revenue, generating approximately $500 million annually. This positions Blink Health as a significant player in the discount prescription space, competing directly with GoodRx's extensive offerings and customer base.

What are goodrx’s key strengths compared to competitors?

GoodRx excels in providing extensive discounts on prescriptions, superior user experience through its mobile app, and comprehensive drug information. These strengths allow users to efficiently navigate their options, ensuring they receive the best prices and are well-informed about their medications, which is essential for informed healthcare decisions.

Where can I find a detailed comparison of goodrx and its competitors?

For a detailed comparison of GoodRx and its competitors, you can access our services at Custom Research on Consainsights.com. Additionally, you can review our Research Methodology to understand how we evaluate these companies comprehensively.